Answers are grounded in this paper and cite their sources.
Purpose This study investigated genetic alterations in recurrent maxillary ameloblastoma with pulmonary metastases. Methods We analyzed tissue from a patient with a fifth recurrence of maxillary ameloblastoma and bilateral pulmonary metastases who underwent resection of the maxillary and lung lesions. Immunohistochemistry (IHC) for CK19, p53, and MIB1 was performed on the recurrent maxillary tumor and metastatic lung lesions. Genetic alterations were evaluated using a 225-gene cancer panel. Results Histologically, the recurrent maxillary tumor showed moderate atypia, whereas the metastatic lung tumor showed mild atypia. IHC demonstrated focal p53 positivity in the recurrent maxillary tumor and diffuse p53 positivity in the metastatic lung tumor. Genomic analysis identified identical SMO (L412F) and PIK3CA (E545K) mutations in the recurrent maxillary tumor and metastatic lung lesion. Conclusion These findings support the involvement of Hedgehog and phosphoinositide 3-kinase (PI3K) signaling in the pathogenesis of metastatic maxillary ameloblastoma and demonstrate the potential value of genetic profiling for identifying therapeutic targets in aggressive or metastatic odontogenic tumors.
No takes yet. Share an insight, caveat, or question.
Yagamuchi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: